A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth-Reference-Cited by-同舟云学术

A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth

Published:2016-06-14 Issue:28 Volume:7 Page:44299-44309
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Pan Ting¹²³,Zhang Yiwen¹²³,Zhou Nan¹²³,He Xin¹²³,Chen Cancan¹²³,Liang Liting¹³,Duan Xiaobing¹²,Lin Yingtong¹³,Wu Kang¹²³,Zhang Hui¹²³

Affiliation:

1. Institute of Human Virology, Sun Yat-Sen University, Guangzhou, Guangdong, China

2. Key Laboratory of Tropical Diseases Control, Ministry of Education, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China

3. Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies;Frontiers in Pharmacology;2024-07-26

2. Systemic Administration of Neurotransmitter‐Derived Lipidoids‐PROTACs‐DNA Nanocomplex Promotes Tau Clearance and Cognitive Recovery for Alzheimer's Disease Therapy;Advanced Healthcare Materials;2024-07-15

3. Degraders upgraded: the rise of PROTACs in hematological malignancies;Blood;2024-03-28

4. Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach;Journal of Biological Chemistry;2023-12

5. Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications;European Journal of Medicinal Chemistry;2023-09